Primary Recipient

TENSIVE CONTROLS, INC.

Amount

$199,345.00

Award Date

6/18/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

CDFA Program Title

Description

This project has the long-term goal of developing melanocortin receptor (MCR) antagonists as therapeutic drugs for cachexia. Cachexia, characterized by a lack of appetite and a loss of lean body mass, is a frequent complication of malignancy, infec